Murizatoclax
Murizatoclax (AMG 397) is a potent, selective and orally active inhibitor of myeloid leukemia 1 (MCL-1) inhibitor, with a Ki of 15 pM. Murizatoclax competitive binds to the BH3-binding groove of MCL1 with pro-apoptotic BCL-2 family members. Murizatoclax can be used for the research of cancer[1][2].
Product Specifications
CAS Number
2245848-05-7
Product Name Alternative
AMG 397
UNSPSC
12352005
Target
Bcl-2 Family
Type
Reference compound
Related Pathways
Apoptosis
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/murizatoclax.html
Purity
98.84
Solubility
DMSO : 10 mg/mL (ultrasonic)
Smiles
O=C(C(C=C1)=CC2=C1OC[C@]3(CCCC4=C3C=CC(Cl)=C4)CN2C[C@@]5([H])[C@](CC5)([H])[C@](CN6C[C@](CCCC7)([H])N7CC6)(OC)/C=C/C[C@H](C)[C@H]8C)NS8(=O)=O
Molecular Formula
C42H57ClN4O5S
Molecular Weight
765.44
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 1
Isoform
Mcl-1
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Clusterin/Apolipoprotein J/Apo-J/CLU Monoclonal Antibody
Cyclophilin A (PPIA) (NM_021130) Human Recombinant Protein
